Vaxxas gains Australia’s TGA licence to manufacture HD microarray patch
December 15, 2025
The patch is tailored to deliver all types of vaccines to the skin using a simple applicator.
The patch is tailored to deliver all types of vaccines to the skin using a simple applicator.
The FDA has granted Breakthrough Device Designation to Nephrodite’s Holly implantable continuous dialysis system.
Though an estimated 60 million people around the world have atrial fibrillation, or A-fib, a type of irregular and often fast heartbeat, it’s been at least 30 years since any new treatments have been developed. This is because researchers haven’t had accurate models of the human heart to study. Thanks to new developments from Michigan State University scientists, that is no longer the case.
Study is first to show how tanning beds mutate skin cells far beyond the reach of ordinary sunlight
The Spring is the only FDA-approved FIT in a range of lengths and diameters, allowing for patient personalisation
A study published in the Journal of Clinical Oncology confirms that one of the first Food and Drug Administration-approved CAR-T cell therapies offers long-term survival and potential cures for adult patients with relapsed or refractory large B-cell lymphoma, even years after treatment.
Heart muscle cells grown from patient stem cells—known as human induced pluripotent stem cell–derived cardiomyocytes, or hiPSC-CMs—are a promising way to repair hearts damaged by heart attacks and heart failure.
Flow Neuroscience’s at-home depression treatment device has become the first of its kind to be approved by the FDA.
Lumos Labs’ LumosityRx is positioned for use alongside other ADHD treatment modalities such as medication and therapy.
Synaptic plasticity—the brain’s ability to modify the connections between neurons to support learning—is one of the neural functions profoundly altered in Huntington’s disease, with a direct impact on brain function.